Literature DB >> 2194654

Metabolic activation of the potent mutagen, 2-naphthohydroxamic acid, in Salmonella typhimurium TA98.

M S Lee1, M Isobe.   

Abstract

The objective of the present study was to explore the mechanisms responsible for the strong, direct-acting mutagenicity of 2-naphthohydroxamic acid (NHA) for Salmonella typhimurium TA98. NHA was converted to its O-acetate (O-Ac-NHA) by acetyl-CoA, in the presence of competent or heat-treated cell-free bacterial preparations. O-Ac-NHA, which is more mutagenic than NHA, reacted nonenzymatically with tRNA in neutral solutions with retention of both the naphthyl and carbonyl groups in the products, but NHA did not react. Enzymatic sulfate conjugation was not demonstrated. TA98 cells converted NHA to 2-aminoaphthalene, presumably through a Lossen rearrangement following O-acetylation or conjugation by other metabolic pathways. TA98 cells reduced O-Ac-NHA to 2-naphthamide, and NADH and NADPH were shown to be cofactors for reduction in the presence of a cell-free bacterial preparation. Although horseradish peroxidase and H2O2 catalyzed the binding of these compounds to tRNA, no evidence of oxidation of NHA or O-Ac-NHA was obtained with H2O2 and cell-free preparations of TA98 or the cells themselves, as judged by the lack of formation of the peroxidative product, 2-naphthoic acid. Both NHA and O-Ac-NHA reacted with DNA of TA98 with retention of both naphthyl group and carbonyl of the naphthoyl moiety in the adduct(s). These results suggest that NHA may be activated in TA98 by esterification, and the resulting metabolites may amidate or carbamoylate nucleic acids.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2194654

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

1.  Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors--What Some May Have Forgotten or Would Rather Forget?

Authors:  Sida Shen; Alan P Kozikowski
Journal:  ChemMedChem       Date:  2015-11-25       Impact factor: 3.466

2.  Assessment of the trifluoromethyl ketone functionality as an alternative zinc-binding group for selective HDAC6 inhibition.

Authors:  Yves Depetter; Silke Geurs; Flore Vanden Bussche; Rob De Vreese; Jorick Franceus; Tom Desmet; Olivier De Wever; Matthias D'hooghe
Journal:  Medchemcomm       Date:  2018-05-18       Impact factor: 3.597

3.  In Vitro Assessment of the Genotoxic Hazard of Novel Hydroxamic Acid- and Benzamide-Type Histone Deacetylase Inhibitors (HDACi).

Authors:  Annabelle Friedrich; Ann-Sophie Assmann; Lena Schumacher; Jana V Stuijvenberg; Matthias U Kassack; Wolfgang A Schulz; Wynand P Roos; Finn K Hansen; Marc Pflieger; Thomas Kurz; Gerhard Fritz
Journal:  Int J Mol Sci       Date:  2020-07-03       Impact factor: 5.923

Review 4.  Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives.

Authors:  Robert Jenke; Nina Reßing; Finn K Hansen; Achim Aigner; Thomas Büch
Journal:  Cancers (Basel)       Date:  2021-02-05       Impact factor: 6.639

Review 5.  Leaks in the Pipeline: a Failure Analysis of Gram-Negative Antibiotic Development from 2010 to 2020.

Authors:  Neha K Prasad; Ian B Seiple; Ryan T Cirz; Oren S Rosenberg
Journal:  Antimicrob Agents Chemother       Date:  2022-04-26       Impact factor: 5.938

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.